Back to Resource Center

Interim open-label study results suggest higher dapivirine vaginal ring use, lower HIV risk

Interim open-label study results suggest higher dapivirine vaginal ring use, lower HIV risk

March 2018

Click to view Media / News Article

Click for full info +

Full Info:

Resource Type:

Media / News Article

Citation:

IPM. (2018, March 6). Medical Express.

Health Risks(s):

HIV
Unintended Pregnancy

Product type(s):

Contraceptives
IVR
MPTs

Topic(s):

MPTs
Development

URL of resource:

https://medicalxpress.com/news/2018-03-interim-open-label-results-higher-dapivirine.html

Back to Resource Center